- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on SARS CoV-2
Total 12021 results
-
Providence Health & ServicesOncoSec Medical IncorporatedCompleted
-
GeneOne Life Science, Inc.Active, not recruiting
-
ModernaTX, Inc.CompletedSARS-CoV-2United States
-
Genexine, Inc.Active, not recruitingSARS-CoV-2Korea, Republic of
-
I.M. Sechenov First Moscow State Medical UniversityProkhorov General Physics Institute of the Russian Academy of Sciences (GPI...Completed
-
E25Bio, Inc.SCRI Development Innovations, LLCCompleted
-
ModernaTX, Inc.Recruiting
-
ModernaTX, Inc.Completed
-
Glycovax Pharma Inc.Government of Canada; JSS Medical Research Inc.; Seppic; Avance Clinical Pty Ltd.Active, not recruiting
-
Genexine, Inc.CompletedSARS-CoV-2Korea, Republic of
-
Institut National de la Santé Et de la Recherche...Completed
-
ModernaTX, Inc.Completed
-
Ology BioservicesEnabling Biotechnologies (EB)CompletedSARS-CoV-2United States
-
ModernaTX, Inc.Terminated
-
Direction Centrale du Service de Santé des ArméesCompleted
-
ModernaTX, Inc.Completed
-
Johns Hopkins UniversityNational Institute of Allergy and Infectious Diseases (NIAID); United States... and other collaboratorsCompletedSARS-CoV 2United States
-
ModernaTX, Inc.Biomedical Advanced Research and Development AuthorityCompleted
-
Centre Hospitalier Universitaire VaudoisCompletedSARS-CoV-2Switzerland
-
Collegium Medicum w BydgoszczyActive, not recruitingSARS-CoV2 Infection | SARS-CoV2 AntibodiesPoland
-
AIM Vaccine Co., Ltd.Ningbo Rongan Biological Pharmaceutical Co. Ltd.; LiveRNA Therapeutics Inc.; AIM...Recruiting
-
ModernaTX, Inc.RecruitingSARS-CoV-2United States, Puerto Rico
-
University of PennsylvaniaNot yet recruiting
-
AstraZenecaCompletedSARS-CoV-2United States, Belgium, United Kingdom, Brazil, Germany
-
ModernaTX, Inc.Aetion, Inc.Active, not recruiting
-
Entos Pharmaceuticals Inc.Canadian Institutes of Health Research (CIHR); Aegis Life, Inc.; Clinical Pharma... and other collaboratorsCompletedSARS-CoV-2Burkina Faso, Canada, Senegal, South Africa
-
Yale UniversityCompletedSARS-CoV-2United States
-
AIM Vaccine Co., Ltd.First Affiliated Hospital Bengbu Medical College; Ningbo Rongan Biological...Active, not recruiting
-
Convergent Genomics, Inc.Completed
-
ModernaTX, Inc.CompletedSARS-CoV-2United States
-
Illumina, Inc.Helix OpCo, LLCCompletedSARS-CoV-2United States
-
Illumina, Inc.Helix OpCo, LLCCompletedSARS-CoV-2United States
-
Genexine, Inc.Active, not recruitingSARS-CoV-2Korea, Republic of
-
Icahn School of Medicine at Mount SinaiEiger BioPharmaceuticalsWithdrawnSARS-CoV-2
-
Coordinación de Investigación en Salud, MexicoInstituto Mexicano del Seguro SocialUnknown
-
University of Sao PauloUnknown
-
Tonix Pharmaceuticals, Inc.Premier Research Group plcActive, not recruitingDetection of Delayed-type Hypersensitivity Reactions to SARS-CoV-2 in Individuals Exposed to SARS-CoV-2United States
-
Chulalongkorn UniversityRamathibodi Hospital; Ministry of Health, Thailand; The Government Pharmaceutical... and other collaboratorsCompletedSARS-CoV-2 Acute Respiratory Disease | SARS CoV 2 InfectionThailand
-
Azienda Ospedaliero, Universitaria PisanaTerminatedSARS-CoV 2 | COVIDItaly
-
St George's University Hospitals NHS Foundation...Unknown
-
The Second Affiliated Hospital of Chongqing Medical...RecruitingThe Safety and Tolerability of MY-586 COVID-19 Neutralizing Antibody Nasal Spray in Healthy SubjectsSARS-CoV-2 | PreventionChina
-
University of Roma La SapienzaLucia Stefanini; Stefania BasiliRecruiting
-
Centre for Infectious Disease Research in ZambiaMinistry of Health, Zambia; University of ZambiaWithdrawnSARS-CoV-2 | IvermectinZambia
-
Institute of Health Information and Statistics...Institute for Clinical and Experimental Medicine; Brno University Hospital; Masaryk... and other collaboratorsCompletedCOVID | SARS-CoV-2Czechia
-
AstraZenecaActive, not recruitingCOVID-19, SARS-CoV-2Japan
-
Hamad Medical CorporationCompleted
-
University of Wisconsin, MadisonNational Institutes of Health (NIH)Completed
-
Chongqing Medical UniversityCompleted
-
Syneos HealthUS Specialty Formulations, LLCCompletedSARS-CoV-2 (COVID-19)New Zealand